Universe Pharmaceuticals (UPC) Notes Payables (2020 - 2025)
Universe Pharmaceuticals' Notes Payables history spans 6 years, with the latest figure at $7.1 billion for Q3 2025.
- On a quarterly basis, Notes Payables rose 22.08% to $7.1 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $7.1 billion, a 22.08% increase, with the full-year FY2025 number at $7.1 billion, up 22.08% from a year prior.
- Notes Payables hit $7.1 billion in Q3 2025 for Universe Pharmaceuticals, up from $5.9 billion in the prior quarter.
- Over the last five years, Notes Payables for UPC hit a ceiling of $7.1 billion in Q3 2025 and a floor of $3.9 million in Q3 2022.
- Historically, Notes Payables has averaged $1.6 billion across 5 years, with a median of $4.4 million in 2022.
- Biggest five-year swings in Notes Payables: plummeted 100.0% in 2021 and later skyrocketed 106726.27% in 2024.
- Tracing UPC's Notes Payables over 5 years: stood at $4.3 million in 2021, then dropped by 9.19% to $3.9 million in 2022, then soared by 39.28% to $5.5 million in 2023, then skyrocketed by 106726.27% to $5.9 billion in 2024, then increased by 22.08% to $7.1 billion in 2025.
- Business Quant data shows Notes Payables for UPC at $7.1 billion in Q3 2025, $5.9 billion in Q3 2024, and $4.4 million in Q1 2024.